Krzysztof M. Mrozik

North Terrace
Adelaide, SA 5005, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Bortezomib-induced gastrointestinal dysfunction, peripheral neuropathy and neuroimmune signalling are influenced by the gut microbiota in mice.

Bortezomib-induced gastrointestinal dysfunction, peripheral neuropathy and neuroimmune signalling are influenced by the gut microbiota in mice.

Journal: Journal of neuroinflammation

Published: January 12, 2026

N-cadherin mechanosensing in ovarian follicles controls oocyte maturation and ovulation.

N-cadherin mechanosensing in ovarian follicles controls oocyte maturation and ovulation.

Journal: eLife

Published: July 29, 2025

Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism.

Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism.

Journal: Experimental hematology

Published: January 09, 2025

Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma.

Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma.

Journal: Leukemia

Published: June 05, 2024

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.

Journal: Leukemia research

Published: August 03, 2023

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.

Journal: British journal of haematology

Published: May 25, 2023

Mesenchymal stromal cell senescence in haematological malignancies.

Mesenchymal stromal cell senescence in haematological malignancies.

Journal: Cancer metastasis reviews

Published: June 27, 2022

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

Journal: Haematologica

Published: September 10, 2020

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo.

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo.

Journal: Cancers

Published: June 25, 2020

Characterization of the role of Samsn1 loss in multiple myeloma development.

Characterization of the role of Samsn1 loss in multiple myeloma development.

Journal: FASEB bioAdvances

Published: April 26, 2020

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.

Journal: PloS one

Published: October 17, 2019

LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.

LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.

Journal: FASEB bioAdvances

Published: August 28, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026